Minerva Neurosciences (NERV) Accumulated Expenses (2013 - 2018)
Minerva Neurosciences (NERV) reported Accumulated Expenses of $5,217 for Q2 2018, down 85.2% from $35,270 a year earlier and down 59.7% from the prior quarter.
Powered by 
Analysis
Minerva Neurosciences (NERV) Accumulated Expenses (2013 - 2018) Analysis & Trends
At the end of FY2017, Minerva Neurosciences posted Accumulated Expenses of $20,508, down 58.6% from FY2016.
- Accumulated Expenses has a four-year compound annual growth rate of -4.1% (FY2013 to FY2017).
- By year, Accumulated Expenses came in at $49,523 in FY2016 (-15.7%), $58,750 in FY2015 and $24,276 in FY2013.
- The Q2 2018 figure ranks as the lowest quarterly Accumulated Expenses in data going back to Q4 2013.
- Year over year, Accumulated Expenses has now declined in each of the last eight quarters, with an average decline of 43.9% over the last eight quarters.
- The year-over-year decline in Accumulated Expenses has ranged between 0.0% (Q2 2016) and 97.5% (Q2 2015) over the last five years.
- Per Business Quant data, the three quarters before Q2 2018 came in at $12,930 (Q1 2018), $20,508 (Q4 2017) and $27,954 (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Minerva Neurosciences | 124.09 Mn | -188.49 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 5,217.00 |
| Mar 31, 2018 | 12,930.00 |
| Dec 31, 2017 | 20,508.00 |
| Sep 30, 2017 | 27,954.00 |
| Jun 30, 2017 | 35,270.00 |
| Mar 31, 2017 | 42,459.00 |
| Dec 31, 2016 | 49,523.00 |
| Sep 30, 2016 | 56,463.00 |
| Jun 30, 2016 | 58,750.00 |
| Mar 31, 2016 | 58,750.00 |
| Dec 31, 2015 | 58,750.00 |
| Sep 30, 2015 | 58,750.00 |
| Jun 30, 2015 | 58,750.00 |
| Mar 31, 2015 | 58,750.00 |
| Sep 30, 2014 | 100,000.00 |
| Jun 30, 2014 | 2.34 Mn |
| Dec 31, 2013 | 24,276.00 |
API Access
Minerva Neurosciences Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();